Liver-like human cells can be generated from human skin by converting fibroblasts to "induced pluripotent stem cells" (iPSCs), then differentiating the iPSCs into "induced hepatocytes". Although still primarily used as a research tool, emerging applications involving iPSC-derived induced hepatocytes have exciting and provocative clinical and translational potential. This review provides a brief summary of the current status of this field and obstacles that must be overcome before this novel tool will enable precision medicine-based approaches to human liver disease.

Original languageEnglish
Pages (from-to)716-719
Number of pages4
JournalJournal of pediatric gastroenterology and nutrition
Issue number5
StatePublished - May 1 2018


  • drug development
  • hepatotoxicity
  • induced hepatocytes
  • induced pluripotent stem cell
  • liver disease
  • liver regeneration


Dive into the research topics of 'Induced Pluripotent Stem Cell-Derived Hepatocytes and Precision Medicine in Human Liver Disease'. Together they form a unique fingerprint.

Cite this